(PharmaNewsWire.Com, April 19, 2017 ) Trend towards growing incidence of organ and tissue failure diseases is helping the market to compete across the globe. The market growth is fostered by some of the factors such as immensely enhanced immunosuppression regimens, advance tissue matching and improved harvesting and procurement techniques. However, shortage of organ donors and artificial organs will reflect the market strength. Moreover, huge investments in R&D will pose an opportunity for the organ and tissue transplantation market over the forecast period. By tissue transplantation, bone graft transplantation is a fastest growing segment during the forecast period.
Some of the key players in this market include Johnson & Johnson, Medtronic Plc, Novartis AG, St. Jude Medical, Inc., World Heart Corporation, Edwards Lifescience, Lifeblood Medical, Inc, ABIOMED, Inc, Roche Pharmaceuticals and Stryker Corporation.
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
Company Profiling 10.1 Johnson & Johnson 10.2 Medtronic Plc 10.3 Novartis AG 10.4 St. Jude Medical, Inc. 10.5 World Heart Corporation 10.6 Edwards Lifescience 10.7 Lifeblood Medical, Inc 10.8 ABIOMED, Inc 10.9 Roche Pharmaceuticals 10.10 Stryker Corporation 10.11 LifeCell Corporation 10.12 Organogenesis Inc. 10.13 HemoCleanse, Inc. 10.14 ViroPharma Inc. 10.15 PDL BioPharma
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
